CNTA

Centessa Pharmaceuticals
CNTA

Upgrade to unlock
Buy
Hold
Sell

2 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
Avg. target
$39
2% downside
High target

2 analyst ratings

positive
0  neutral
0%
negative
Analyst & Firm Rating Price Target Upside
Downside 		Date
Wolfe Research
Wolfe Research
Rudy Li
100% 1-yr CNTA win rate
24 Feb ‘26 1 month ago
Truist Securities
Truist Securities
Danielle Brill
100% 1-yr CNTA win rate
29 Jan ‘26 2 months ago